• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去 SUMO 酶 SENP1 介导的拓扑异构酶 I 抑制剂的抗白血病作用。

Antileukemic effects of topoisomerase I inhibitors mediated by de-SUMOylase SENP1.

机构信息

Clinical Research Center, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166492. doi: 10.1016/j.bbadis.2022.166492. Epub 2022 Jul 16.

DOI:10.1016/j.bbadis.2022.166492
PMID:35850175
Abstract

SUMO-specific proteases (SENPs) play pivotal roles in maintaining the balance of SUMOylation/de-SUMOylation and in SUMO recycling. Deregulation of SENPs leads to cellular dysfunction and corresponding diseases. As a key member of the SENP family, SENP1 is highly correlated with various cancers. However, the potential role of SENP1 in leukemia, especially in acute lymphoblastic leukemia (ALL), is not clear. This study shows that ALL cells knocking down SENP1 display compromised growth rather than significant alterations in chemosensitivity, although ALL relapse samples have a relatively higher expression of SENP1 than the paired diagnosis samples. Camptothecin derivatives 7-ethylcamptothecin (7E-CPT, a monomer compound) and topotecan (TPT, an approved clinical drug) induce specific SENP1 reduction and severe apoptosis of ALL cells, showing strong anticancer effects against ALL. Conversely, SENP1 could attenuate this inhibitory effect by targeting DNA topoisomerase I (TOP1) for de-SUMOylation, indicating that specific reduction in SENP1 induced by 7E-CPT and/or topotecan inhibits the proliferation of ALL cells.

摘要

SUMO 特异性蛋白酶(SENPs)在维持 SUMO 化/去 SUMO 化平衡和 SUMO 循环中发挥关键作用。SENPs 的失调会导致细胞功能障碍和相应的疾病。作为 SENP 家族的关键成员,SENP1 与多种癌症高度相关。然而,SENP1 在白血病,特别是急性淋巴细胞白血病(ALL)中的潜在作用尚不清楚。本研究表明,敲低 SENP1 的 ALL 细胞显示出生长受损,而不是对化学敏感性的显著改变,尽管 ALL 复发样本的 SENP1 表达相对高于配对的诊断样本。喜树碱衍生物 7-乙基喜树碱(7E-CPT,一种单体化合物)和拓扑替康(TPT,一种已批准的临床药物)诱导 ALL 细胞中特定的 SENP1 减少和严重凋亡,对 ALL 具有强烈的抗癌作用。相反,SENP1 可以通过靶向 DNA 拓扑异构酶 I(TOP1)进行去 SUMO 化来减弱这种抑制作用,表明 7E-CPT 和/或拓扑替康特异性降低 SENP1 抑制 ALL 细胞的增殖。

相似文献

1
Antileukemic effects of topoisomerase I inhibitors mediated by de-SUMOylase SENP1.去 SUMO 酶 SENP1 介导的拓扑异构酶 I 抑制剂的抗白血病作用。
Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166492. doi: 10.1016/j.bbadis.2022.166492. Epub 2022 Jul 16.
2
SENP1 participates in Irinotecan resistance in human colon cancer cells.SENP1 参与人结肠癌细胞对伊立替康的耐药性。
J Cell Biochem. 2021 Oct;122(10):1277-1294. doi: 10.1002/jcb.29946. Epub 2021 May 26.
3
N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.IGF2BP3 识别的 N6-甲基腺苷修饰的 SENP1 是急性髓系白血病的新型分子标志物,通过去 SUMO 化 HDAC2 激活 AKT 信号加重疾病进展。
Mol Cancer. 2024 May 31;23(1):116. doi: 10.1186/s12943-024-02013-y.
4
SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.SENP1 参与 Elk-1 的 SUMOylation 的动态调节。
Biochem J. 2010 May 13;428(2):247-54. doi: 10.1042/BJ20091948.
5
Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.SUMO化负向调控CSR1依赖性前列腺癌细胞死亡。
Cell Physiol Biochem. 2018;46(5):1861-1867. doi: 10.1159/000489370. Epub 2018 Apr 25.
6
SENP1-mediated NEMO de-SUMOylation inhibits intermittent hypoxia induced inflammatory response of microglia in vitro.SENP1 介导的 NEMO 去 SUMOylation 抑制体外间歇性低氧诱导的小胶质细胞炎症反应。
J Cell Physiol. 2020 Apr;235(4):3529-3538. doi: 10.1002/jcp.29241. Epub 2019 Sep 24.
7
SENP1 modulates microglia-mediated neuroinflammation toward intermittent hypoxia-induced cognitive decline through the de-SUMOylation of NEMO.SENP1 通过去 SUMO 化 NEMO 调节小胶质细胞介导的神经炎症,从而导致间歇性低氧诱导的认知功能下降。
J Cell Mol Med. 2021 Jul;25(14):6841-6854. doi: 10.1111/jcmm.16689. Epub 2021 Jun 13.
8
SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.小泛素样修饰蛋白化作用可保护INS-1 832/13细胞和人胰岛免受白细胞介素-1β诱导的细胞凋亡。
Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E664-73. doi: 10.1152/ajpendo.00168.2014. Epub 2014 Aug 19.
9
Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.乳腺癌中SUMO特异性半胱氨酸蛋白酶-SENP1和SENP2的基因多态性
Pathol Oncol Res. 2016 Oct;22(4):817-23. doi: 10.1007/s12253-016-0064-7. Epub 2016 May 13.
10
MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.MYB 调节 SUMO 蛋白酶 SENP1 及其新的相互作用伙伴 UXT,调节 MYB 靶基因和 SUMO 景观。
J Biol Chem. 2023 Sep;299(9):105062. doi: 10.1016/j.jbc.2023.105062. Epub 2023 Jul 17.

引用本文的文献

1
Targeted deprivation of STAT6 sensitizes acute lymphoblastic leukemia cells to cytarabine in vivo and in vitro: clinical implications.靶向性去除信号转导与转录激活因子6使急性淋巴细胞白血病细胞在体内和体外对阿糖胞苷敏感:临床意义
Cell Death Dis. 2025 Sep 2;16(1):669. doi: 10.1038/s41419-025-07981-7.
2
Endophytic fungi as a potential source of anti-cancer drug.内生真菌作为抗癌药物的潜在来源。
Arch Microbiol. 2024 Feb 26;206(3):122. doi: 10.1007/s00203-024-03829-4.
3
Emerging role of SENP1 in tumorigenesis and cancer therapy.SENP1在肿瘤发生和癌症治疗中的新作用。
Front Pharmacol. 2024 Feb 8;15:1354323. doi: 10.3389/fphar.2024.1354323. eCollection 2024.
4
Etoposide-induced SENP8 confers a feed-back drug resistance on acute lymphoblastic leukemia cells.依托泊苷诱导的SENP8赋予急性淋巴细胞白血病细胞反馈性耐药。
Biochem Biophys Rep. 2024 Jan 25;37:101650. doi: 10.1016/j.bbrep.2024.101650. eCollection 2024 Mar.
5
The emerging roles of SUMOylation in pulmonary diseases.SUMOylation 在肺部疾病中的新兴作用。
Mol Med. 2023 Sep 5;29(1):119. doi: 10.1186/s10020-023-00719-1.